Findings presented at the European Respiratory Society Congress 2026 suggest semaglutide may offer respiratory benefits beyond its approved diabetes and obesity indications.
|Articles|January 20, 2022
Daily Medication Pearl: Cyclosporine Ophthalmic Solution (Cequa)
Author(s)Saro Arakelians, PharmD
Cequa ophthalmic solution is indicated to increase tear production in patients with dry eyes.
Advertisement
Medication Pearl of the Day: Cyclosporine ophthalmic solution (Cequa)
Indication: Cequa ophthalmic solution is a calcineurin inhibitor immunosuppressant indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eyes).
Insight:
- Dosing: Instill 1 drop of Cequa twice daily (approximately 12 hours apart) into each eye. Discard the vial immediately after using in both eyes.
- Dosage forms: Ophthalmic solution containing cyclosporine 0.9 mg/mL.
- Adverse events (AEs): The most common AEs reported in greater than 5% of subjects were pain on instillation of drops (22%) and conjunctival hyperemia (6%). Other AEs reported in 1% to 5% of the patients were blepharitis, eye irritation, headache, and urinary tract infection.
- Mechanism of action: Cyclosporine is a calcineurin inhibitor immunosuppressant agent when administered systemically.
- Manufacturer: Sun Pharma
Sources:
Advertisement
Related to this article
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
The data helps pharmaicts predict who will react strongly to mRNA vaccines—giving them a science-backed talking point during respiratory season.
CDC-recommended adult vaccination programs for pneumococcal disease, RSV, influenza, and COVID-19 prevent over 182,000 deaths and generate up to $12 in societal value for every $1 spent.
This article discusses a recent publication examining pharmacy access across Minnesota and explores the complex factors contributing to threatened community health access across the US.
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
New European Respiratory Society (ERS) update makes sotatercept a strong add-on recommendation, opening a fourth pathway for pharmacists to manage.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
Dapagliflozin in Heart Failure: Congestion Isn't the Gatekeeper
3
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
4
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
5